Results 1 to 10 of about 2,633 (150)

[Analysis of antiviral efficacy in pediatric patients with HBeAg-negative chronic hepatitis B]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Guo X, Fan PY, Li J, Wang LX, Dong Y, Cao LL, Yan JG, Zhang M, Wang FS.   +8 more
europepmc   +1 more source

[Chinese expert consensus on the diagnosis and management of nodal peripheral T-cell lymphoma (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Lymphoma Expert Committee of Chinese Society of Clinical Oncology (CSCO), Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association.   +3 more
europepmc   +1 more source

[The role and mechanism of chemokine network in promoting osteoarthritis progression by regulating synovial macrophage heterogeneity]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Lin Y, Wu L, Chen Q, Shen B.
europepmc   +1 more source

[Risk Factors, Molecular Mechanisms, and Multimodal Early Warning Strategies 
for Immune Checkpoint Inhibitor-associated Pneumonitis in Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi
Zhan J, Chen X, Li N.
europepmc   +1 more source

[Pathogenic mechanisms of Leber hereditary optic neuropathy caused by m.3472T>C mutation]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Zhang H, Shan W, Yasheng M, Guan M.
europepmc   +1 more source

[Analysis of peripheral blood monocyte subsets in chronic myelomonocytic leukemia: a single-center study]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Wang L, Li MM, Bai JJ, Deng CX, Wu P, Luo CW, Lai PL, Weng JY, Du X.   +8 more
europepmc   +1 more source

[Rapid determination of venetoclax in plasma by ultra performance liquid chromatography-tandem mass spectrometry]. [PDF]

Se Pu
Zhu Y, Ma XL, Yu SL, Qiu L.
europepmc   +1 more source

[IKZF3/Aiolos and tumors]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Jia Q, Shao K, Li Y, Mei Y, Zhang F.
europepmc   +1 more source

[Phase Ⅲ, multicenter, randomized, double-blinded, positive-controlled trial on the efficacy and safety of maribavir compared with valganciclovir in the treatment of post-transplant cytomegalovirus infection: Subgroup analysis of AURORA Trial in the Chinese population]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Xuan L, Huang H, Xu LP, Fu YW, Chen F, Wang Y, Wang SQ, Dong L, Wu JY, Wu DP.   +9 more
europepmc   +1 more source

[Research Progress of Peripheral Immune Tolerance in Oral Diseases]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Wen K, Zhang P, Peng X.
europepmc   +1 more source